{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:38:03Z","timestamp":1788982683252,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.isci.2021.102148","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T03:59:54Z","timestamp":1612670394000},"page":"102148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4685-4656","authenticated-orcid":false,"given":"Zexu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-5700","authenticated-orcid":false,"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2021.102148_bib1","doi-asserted-by":"crossref","first-page":"e02002","DOI":"10.1128\/mBio.02002-18","article-title":"Network-Guided discovery of influenza virus replication host factors","volume":"9","author":"Ackerman","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.isci.2021.102148_bib2","doi-asserted-by":"crossref","first-page":"101303","DOI":"10.1016\/j.isci.2020.101303","article-title":"Current status of COVID-19 therapies and drug repositioning applications","volume":"23","author":"Altay","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.isci.2021.102148_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-infected host cells reveals therapy targets","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.102148_bib4","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3389\/fimmu.2019.02186","article-title":"Common nodes of virus-host interaction revealed through an integrated network analysis","volume":"10","author":"Bosl","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2021.102148_bib5","doi-asserted-by":"crossref","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","article-title":"DGIdb 3.0: a redesign and expansion of the drug-gene interaction database","volume":"46","author":"Cotto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2021.102148_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.drudis.2020.03.003","article-title":"Machine learning models for drug-target interactions: current knowledge and future directions","volume":"25","author":"D'Souza","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2021.102148_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.102148_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2021.102148_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2019.05.010","article-title":"Recent update on anti-dengue drug discovery","volume":"176","author":"Dighe","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2021.102148_bib10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/AAC.02496-13","article-title":"Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in\u00a0vitro","volume":"58","author":"Gavegnano","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2021.102148_bib11","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2021.102148_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.102148_bib13","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.3892\/etm.2017.4958","article-title":"Sophocarpine against enterovirus 71 in\u00a0vitro","volume":"14","author":"Jin","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.isci.2021.102148_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.isci.2021.102148_bib15","doi-asserted-by":"crossref","first-page":"D552","DOI":"10.1093\/nar\/gkp937","article-title":"Stitch 2: an interaction network database for small molecules and proteins","volume":"38","author":"Kuhn","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2021.102148_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.drudis.2019.01.018","article-title":"Repurposing host-based therapeutics to control coronavirus and influenza virus","volume":"24","author":"Li","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2021.102148_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.isci.2021.102148_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13059-015-0843-6","article-title":"Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR","volume":"16","author":"Li","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2021.102148_bib19","doi-asserted-by":"crossref","first-page":"e9357","DOI":"10.7717\/peerj.9357","article-title":"Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach","volume":"8","author":"Loganathan","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.isci.2021.102148_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41467-017-00680-8","article-title":"A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information","volume":"8","author":"Luo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2021.102148_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.102148_bib22","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.drudis.2018.06.014","article-title":"The A-Z of Zika drug discovery","volume":"23","author":"Mottin","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2021.102148_bib23","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2021.102148_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2021.102148_bib25","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/bib\/bby061","article-title":"Recent applications of deep learning and machine intelligence on in\u00a0silico drug discovery: methods, tools and databases","volume":"20","author":"Rifaioglu","year":"2019","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.isci.2021.102148_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/v10090453","article-title":"Host-directed antivirals: a realistic alternative to fight Zika virus","volume":"10","author":"Saiz","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2021.102148_bib27","doi-asserted-by":"crossref","first-page":"e12697","DOI":"10.15252\/emmm.202012697","article-title":"Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients","author":"Stebbing","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2021.102148_bib28","doi-asserted-by":"crossref","first-page":"D963","DOI":"10.1093\/nar\/gky963","article-title":"DrugCentral 2018: an update","volume":"47","author":"Ursu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2021.102148_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.gpb.2019.04.003","article-title":"DeepCPI: a deep learning-based framework for large-scale in\u00a0silico drug screening","volume":"17","author":"Wan","year":"2019","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.isci.2021.102148_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2021.102148_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2021.102148_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2021.102148_bib33","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2174\/0929867325666180706112940","article-title":"Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development","volume":"26","author":"Zhang","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.isci.2021.102148_bib34","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/molecules24091714","article-title":"Revealing drug-target interactions with computational models and algorithms","volume":"24","author":"Zhou","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2021.102148_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.isci.2021.102148_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2021.102148_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T14:29:32Z","timestamp":1731853772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004221001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2589004221001164"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2021.102148","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.12927260","asserted-by":"object"},{"id-type":"doi","id":"10.26434\/chemrxiv.12927260.v1","asserted-by":"object"}]},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2021.102148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"102148"}}